Literature DB >> 2834062

Proteolysis of tubulin and microtubule-associated proteins 1 and 2 by calpain I and II. Difference in sensitivity of assembled and disassembled microtubules.

M Billger1, M Wallin, J O Karlsson.   

Abstract

Calpain I and II (EC 3.4.22.17) are Ca2+-activated neutral thiol-proteases. Isolated brain tubulin and microtubule-associated proteins were found to be good substrates for proteolytic degradation by brain calpain I and II. The assembly of microtubules was totally inhibited when the calpains were allowed to act on microtubule proteins initially, and a complete disassembly was found after addition of calpain I to assembled microtubules. The high-molecular weight microtubule-associated proteins were degraded within a few minutes following incubation with calpain as shown by SDS-polyacrylamide gel electrophoresis and electron microscopy. When calpain was added to pre-formed microtubules, either in the presence or in the absence of microtubule-associated proteins, the proteolysis was significantly reduced. When tubulin was pre-assembled by taxol, the formation of proteolytic fragments was decreased indicating that assembly alters the availability of tubulin sites for proteolytic cleavage by calpain. Digested tubulin spontaneously formed aberrant polymers. No considerable change of apparent net charge was seen, thus indicating that calpain cleaves off fragments containing neutral amino acid residues and/or that the fragments of tubulin remain associated as an entity with the same charge as native tubulin. The results suggest that the calpains act as irreversible microtubule regulators.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2834062     DOI: 10.1016/0143-4160(88)90036-x

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  29 in total

1.  Immunoelectron microscopic study of tubulin and microtubule-associated proteins after transient cerebral ischemia in gerbils.

Authors:  H Tomimoto; T Yanagihara
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  The susceptibility of MAP-2 to proteolytic degradation increases when bound to tubulin.

Authors:  E Grau; V Felipo; M D Miñana; S Grisolía
Journal:  Neurochem Res       Date:  1992-10       Impact factor: 3.996

3.  Differential vulnerability of microtubule components in cerebral ischemia.

Authors:  T Yanagihara; J M Brengman; W E Mushynski
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

4.  Investigation of the role of calpain as a stimulus-response mediator in human platelets using new synthetic inhibitors.

Authors:  J Anagli; J Hagmann; E Shaw
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

5.  Calpastatin overexpression protects axonal transport in an in vivo model of traumatic axonal injury.

Authors:  Marek Ma; Frances S Shofer; Robert W Neumar
Journal:  J Neurotrauma       Date:  2012-08-29       Impact factor: 5.269

6.  Calpain-mediated proteolysis of microtubule associated proteins MAP1B and MAP2 in developing brain.

Authors:  I Fischer; G Romano-Clarke; F Grynspan
Journal:  Neurochem Res       Date:  1991-08       Impact factor: 3.996

Review 7.  Calmodulin-binding proteins as calpain substrates.

Authors:  K K Wang; A Villalobo; B D Roufogalis
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

8.  Mechanical membrane injury induces axonal beading through localized activation of calpain.

Authors:  Devrim Kilinc; Gianluca Gallo; Kenneth A Barbee
Journal:  Exp Neurol       Date:  2009-07-18       Impact factor: 5.330

9.  Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat.

Authors:  K E Saatman; H Murai; R T Bartus; D H Smith; N J Hayward; B R Perri; T K McIntosh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

Review 10.  Role of calpains in the injury-induced dysfunction and degeneration of the mammalian axon.

Authors:  Marek Ma
Journal:  Neurobiol Dis       Date:  2013-08-19       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.